Option chain shows key data for Precipio's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Precipio.

Precipio (NASDAQ:PRPO) Stock, Option Chain

Precipio

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

Earnings

News

Penny Stocks

Eurozone

Commodities

Small Cap

Global

Intraday Update

Markets

CVNA

EXPI

PRPO

U.S. stocks traded higher toward the end of trading, with Dow Jones gaining more than 150 points on Thursday.

The Dow traded up 0.53% to 33,844.18 while the NASDAQ rose 0.90% to 13,223.26. The S&amp;P 500, also rose, gaining, 0.57% to 4,291.82.

Crude Oil Moves Lower; Carvana Shares Surge

Movers

Trading Ideas

ACON

APRN

BAOS

CNVS

CRGO

FDMT

FFIE

FLGC

HSDT

HYZN

MDGS

MGRX

Airspan Networks Holdings Inc. Common Stock

MIMO

PRSO

PUYI

QBTS

RCEL

RENT

REVG

RNAZ

SCWX

SLDP

SMAR

SNTG

ZUMZ

Gainers


	Baosheng Media Group Holdings Limited  (NASDAQ: BAOS) shares climbed 91.2% to $10.81.


Why Oxford Industries Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday&#39;s Mid-Day Session

U.S. stocks traded higher midway through trading, with Nasdaq Composite gaining over 100 points on Thursday.

The Dow traded up 0.21% to 33,735.90 while the NASDAQ rose 0.94% to 13,228.32. The S&amp;P 500, also rose, gaining, 0.42% to 4,285.24.

Nasdaq Surges Over 100 Points; Signet Jewelers Shares Tumble After Q1 Results

Precipio Inc

Press Releases

General

Precipio Inc. Announces Adjournment of Annual Meeting of Stockholders

Precipio Reports $4.4M for Q2-2024 (unaudited) Revenues, a leap of 30% from Q1-2024

Precipio Reports $0.3M cash generated by operations (unaudited) in Q2-2024, as the company advances towards breakeven

Precipio Announces Q2-2024 Shareholder Update Call

Health Care

Precipio Announces Employee Stock Option Plan Repricing

Precipio Expands Bloodhound™ MPN Panel by Adding CALR Mutation Subtyping

Precipio Announces Q3-2024 Shareholder Update Call

Precipio grants senior management performance-based awards instead of traditional time-vested ESOPs

Precipio Achieves Key Q4-2024 Financial Goals: Positive Adjusted EBITDA and Positive Cash Flow (unaudited)

Precipio Announces Q4 and year-end 2024 Shareholder Update Call

AirSculpt Technologies, Inc. - Common Stock

AirSculpt Technologies

American Shared Hospital Services Common Stock

American Shared Hospital

Biodesix

Basel Medical Group Ltd - ordinary shares

Basel Medical Group

Cryo-Cell International, Inc. Common Stock

Cryo-Cell International

Enzo Biochem, Inc. Common Stock ($0.01 Par Value)

Enzo Biochem

Kindly MD

Mobile-health Network Solutions - Class A Ordinary Shares

Mobile-health Network

ModivCare

MSP Recovery, Inc. - Class A Common Stock

MSP Recovery

NewGenIvf Group Limited - Class A Ordinary Shares

NewGenIvf Group

Ontrak

P3 Health Partners Inc. - Class A Common Stock

P3 Health Partners

Prenetics Global Limited - Class A Ordinary Share

Prenetics Global

SHL Telemedicine Ltd - American Depositary Shares

SHL Telemedicine

Syra Health

Vivos Therapeutics

Comments

Precipio

Precipio (PRPO) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga